MedTrace Logo

Different Lipid Soluble Opioids for Gynecologic Laparoscopic Surgery Postoperative Patient-controlled Analgesia

NCT01917045 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2013-08-06

No results posted yet for this study

Summary

The investigators noticed that Body Fat Ratio might have great influence on the efficacy of different lipid soluble anesthetics. The objective of this clinical trial was to compare the effect of that Body Fat Ratio on the efficacy of different lipid soluble anesthetics.

Conditions

  • Post Operative Pain Management

Interventions

DRUG

Sufentanil (R30730, brand name Sufenta)

sufentanil 1ug/ml

DRUG

Sufentanil (R30730, brand name Sufenta) + Morphine

sufentanil 0.5ug/ml+morphine 0.25mg/ml

DRUG

Morphine

morphine 0. 5mg/ml

Sponsors & Collaborators

  • Peking University First Hospital

    lead OTHER

Principal Investigators

  • zhou yan, MD · PKU 1st hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917045 on ClinicalTrials.gov